BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36958835)

  • 21. Prediabetes in a nursing facility patient with renal insufficiency.
    Shane-McWhorter L
    Consult Pharm; 2010 Jun; 25 Suppl B():11-8. PubMed ID: 20726378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Both Prediabetes and Type 2 Diabetes Are Associated With Lower Heart Rate Variability: The Maastricht Study.
    Coopmans C; Zhou TL; Henry RMA; Heijman J; Schaper NC; Koster A; Schram MT; van der Kallen CJH; Wesselius A; den Engelsman RJA; Crijns HJGM; Stehouwer CDA
    Diabetes Care; 2020 May; 43(5):1126-1133. PubMed ID: 32161051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediabetes and Cardiovascular Disease: Pathophysiology and Interventions for Prevention and Risk Reduction.
    Brannick B; Dagogo-Jack S
    Endocrinol Metab Clin North Am; 2018 Mar; 47(1):33-50. PubMed ID: 29407055
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An investigation of causal relationships between prediabetes and vascular complications.
    Mutie PM; Pomares-Millan H; Atabaki-Pasdar N; Jordan N; Adams R; Daly NL; Tajes JF; Giordano GN; Franks PW
    Nat Commun; 2020 Sep; 11(1):4592. PubMed ID: 32929089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prediabetes: diagnosis, evaluation of chronic complications, and treatment].
    Souza CF; Gross JL; Gerchman F; Leitão CB
    Arq Bras Endocrinol Metabol; 2012 Jul; 56(5):275-84. PubMed ID: 22911279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of early-onset diabetes, prediabetes and early glycaemic recovery with the risk of all-cause and cardiovascular mortality.
    Kim SM; Lee G; Choi S; Kim K; Jeong SM; Son JS; Yun JM; Kim SG; Hwang SS; Park SY; Kim YY; Park SM
    Diabetologia; 2020 Nov; 63(11):2305-2314. PubMed ID: 32820349
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Editorial: Prediabetes: new insights on the diagnosis, risk stratification, comorbidites, cardiovascular disease, microvascular complications, and treatment.
    Neves JS; Buysschaert M; Bergman M
    Front Endocrinol (Lausanne); 2023; 14():1214479. PubMed ID: 37251678
    [No Abstract]   [Full Text] [Related]  

  • 28. Definition of intervention points in prediabetes.
    Ferrannini E
    Lancet Diabetes Endocrinol; 2014 Aug; 2(8):667-75. PubMed ID: 24731662
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inadequacies of absolute threshold levels for diagnosing prediabetes.
    Bergman M
    Diabetes Metab Res Rev; 2010 Jan; 26(1):3-6. PubMed ID: 20101658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The prognostic value of the stress hyperglycemia ratio for all-cause and cardiovascular mortality in patients with diabetes or prediabetes: insights from NHANES 2005-2018.
    Ding L; Zhang H; Dai C; Zhang A; Yu F; Mi L; Qi Y; Tang M
    Cardiovasc Diabetol; 2024 Feb; 23(1):84. PubMed ID: 38419029
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of a Metabolic Syndrome Severity
    DeBoer MD; Filipp SL; Gurka MJ
    Diabetes Care; 2018 Nov; 41(11):2421-2430. PubMed ID: 30275282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Comparison of Biological and Physical Risk Factors for Cardiovascular Disease in Overweight/Obese Individuals With and Without Prediabetes.
    Liu T
    Clin Nurs Res; 2017 Dec; 26(6):674-693. PubMed ID: 27402725
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiovascular risk stratification and management in pre-diabetes.
    Færch K; Vistisen D; Johansen NB; Jørgensen ME
    Curr Diab Rep; 2014 Jun; 14(6):493. PubMed ID: 24743942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Associations Between Frailty and the Increased Risk of Adverse Outcomes Among 38,950 UK Biobank Participants With Prediabetes: Prospective Cohort Study.
    Cao X; Li X; Zhang J; Sun X; Yang G; Zhao Y; Li S; Hoogendijk EO; Wang X; Zhu Y; Allore H; Gill TM; Liu Z
    JMIR Public Health Surveill; 2023 May; 9():e45502. PubMed ID: 37200070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impaired function of fibroblast growth factor 23 / Klotho protein axis in prediabetes and diabetes mellitus: Promising predictor of cardiovascular risk.
    Berezin AE; Berezin AA
    Diabetes Metab Syndr; 2019; 13(4):2549-2556. PubMed ID: 31405675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The early treatment of type 2 diabetes.
    Pratley RE
    Am J Med; 2013 Sep; 126(9 Suppl 1):S2-9. PubMed ID: 23953075
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Should postprandial hyperglycaemia in prediabetic and type 2 diabetic patients be treated?
    Charpentier G; Riveline JP; Dardari D; Varroud-Vial M
    Drugs; 2006; 66(3):273-86. PubMed ID: 16526817
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk of cardiovascular complications related to blood glucose concentration: from diabetes to prediabetes.
    Jenšovský M; Malinovská J; Brunerová L; Vejtasová V; Saldanha R; Kučera K; Brož J
    Vnitr Lek; 2020; 66(7):20-25. PubMed ID: 33380130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metformin Should Not Be Used to Treat Prediabetes.
    Davidson MB
    Diabetes Care; 2020 Sep; 43(9):1983-1987. PubMed ID: 32936780
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiovascular disease risk factors in a Nigerian population with impaired fasting blood glucose level and diabetes mellitus.
    Oguoma VM; Nwose EU; Ulasi II; Akintunde AA; Chukwukelu EE; Bwititi PT; Richards RS; Skinner TC
    BMC Public Health; 2017 Jan; 17(1):36. PubMed ID: 28061844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.